Ali S. Omrani
- Infectious Diseases top 0.5%
- Neurology top 2%
- Epidemiology top 10%
- Molecular Medicine top 1%
- Modeling and Simulation top 1%
- Co-authors
- Ziad A. MemishAli AlbarrakKamran BaigMustafa SaadJaffar A. Al‐TawfiqM. A. MatinSarah ShalhoubReem S. Almaghrabi
- Topics
- SARS-CoV-2 and COVID-19 Research (20 papers)COVID-19 Clinical Research Studies (20 papers)Antibiotic Resistance in Bacteria (19 papers)
- Partner nations
- Saudi ArabiaQatarUnited States
In The Last Decade
Ali S. Omrani
76 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Infectious Diseases 1.8k
- Neurology 531
- Epidemiology 466
- Molecular Medicine 325
- Modeling and Simulation 250
Countries citing papers authored by Ali S. Omrani
This map shows the geographic impact of Ali S. Omrani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali S. Omrani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali S. Omrani more than expected).
Fields of papers citing papers by Ali S. Omrani
This network shows the impact of papers produced by Ali S. Omrani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali S. Omrani. The network helps show where Ali S. Omrani may publish in the future.
Co-authorship network of co-authors of Ali S. Omrani
This figure shows the co-authorship network connecting the top 25 collaborators of Ali S. Omrani. A scholar is included among the top collaborators of Ali S. Omrani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali S. Omrani. Ali S. Omrani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 20 | |
| 6 | 1 | |
| 7 | 8 | |
| 8 | 1 | |
| 9 | 2 | |
| 10 | 19 | |
| 11 | 13 | |
| 12 | 18 | |
| 13 | 20 | |
| 14 | Middle East respiratory syndrome coronavirus: current situation and travel-associated concerns | 1 |
| 15 | The Relationship between Human Capital and Learning Organization Components in Faculty Members of Imam-Khomeini Hospital Complex in 2011 | 0 |
| 16 | Analysis of Thraputic Expenditure in Patients with Multiple Sclerosis in Iran | 3 |
| 17 | Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabiabreakdown → | 391 |
| 18 | 9 | |
| 19 | Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort studybreakdown → | 381 |
| 20 | 5 |
About Ali S. Omrani
Ali S. Omrani is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Infectious Diseases, having authored 79 papers that have together received 2.6k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (20 papers), COVID-19 Clinical Research Studies (20 papers) and Antibiotic Resistance in Bacteria (19 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (220 citations), Infectious Diseases (1.8k citations) and Molecular Medicine (325 citations). Ali S. Omrani has collaborated with scholars based in Saudi Arabia, Qatar and United States. Frequent co-authors include Ziad A. Memish, Ali Albarrak, Kamran Baig, Mustafa Saad, Jaffar A. Al‐Tawfiq, M. A. Matin, Sarah Shalhoub, Reem S. Almaghrabi, Muna Almaslamani and Mohammed Al Mutairi. Their work appears in journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and BMJ.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.